Selective antagonism at dopamine D3 receptors enhances monoaminergic and cholinergic neurotransmission in the rat anterior cingulate cortex (Q44362504)

2 December 2017

Selective antagonism at dopamine D3 receptors enhances monoaminergic and cholinergic neurotransmission in the rat anterior cingulate cortex (English)

1 reference

2 December 2017

0 references

Laurent P Lacroix

1

1 reference

2 December 2017

Mark E P Hows

2

1 reference

2 December 2017

Ajit J Shah

3

1 reference

2 December 2017

Jim J Hagan

4

1 reference

2 December 2017

Christian A Heidbreder

5

1 reference

2 December 2017

language of work or name

English

0 references

publication date

12 March 2003

1 reference

2 December 2017

Neuropsychopharmacology

1 reference

2 December 2017

28

1 reference

2 December 2017

5

1 reference

2 December 2017

839-849

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.npp.1300114

2 December 2017

0 references

cites work

Assessment of cocaine-like discriminative stimulus effects of dopamine D3 receptor ligands.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300114

Effects of scopolamine and physostigmine on recognition memory in monkeys with ibotenic-acid lesions of the nucleus basalis of Meynert

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300114

Do novel antipsychotics have similar pharmacological characteristics? A review of the evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300114

Pharmacokinetics of the novel, high-affinity and selective dopamine D3 receptor antagonist SB-277011 in rat, dog and monkey: in vitro/in vivo correlation and the role of aldehyde oxidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300114

The role of the medial prefrontal cortex of rats in short-term memory functioning: further support for involvement of cholinergic, rather than dopaminergic mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300114

Radioreceptor binding profile of the atypical antipsychotic olanzapine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300114

Modulation of cocaine self-administration in the rat through D-3 dopamine receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300114

D3 receptor test in vitro predicts decreased cocaine self-administration in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300114

Blockade of the noradrenaline carrier increases extracellular dopamine concentrations in the prefrontal cortex: evidence that dopamine is taken up in vivo by noradrenergic terminals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300114

Dopamine in schizophrenia: a review and reconceptualization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300114

Estimation of in-vivo neurotransmitter release by brain microdialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300114

Dissociation of haloperidol, clozapine, and olanzapine effects on electrical activity of mesocortical dopamine neurons and dopamine release in the prefrontal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300114

Acetylcholine release from the frontal cortex during exploratory activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300114

Functional and anatomical aspects of prefrontal pathology in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300114

Phenotypic characterization of neuroleptic-sensitive neurons in the forebrain: contrasting targets of haloperidol and clozapine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300114

Mesolimbic dopamine D3 receptors and use of antipsychotics in patients with schizophrenia. A postmortem study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300114

Distribution of dopamine D3 receptor expressing neurons in the human forebrain: comparison with D2 receptor expressing neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300114

Increased responsiveness of dopamine to atypical, but not typical antipsychotics in the medial prefrontal cortex of rats reared in isolation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300114

Development and application of a sensitive high performance ion-exchange chromatography method for the simultaneous measurement of dopamine, 5-hydroxytryptamine and norepinephrine in microdialysates from the rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300114

Autoradiographic distribution of D3-type dopamine receptors in human brain using [3H]7-hydroxy-N,N-di-n-propyl-2-aminotetralin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300114

Effects of local cholinesterase inhibition on acetylcholine release assessed simultaneously in prefrontal and frontoparietal cortex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300114

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300114

High-performance liquid chromatography/tandem mass spectrometry assay for the rapid high sensitivity measurement of basal acetylcholine from microdialysates

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300114

Atypical, but not typical, antipsychotic drugs increase cortical acetylcholine release without an effect in the nucleus accumbens or striatum

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300114

The noradrenaline-dopamine interaction in the rat medial prefrontal cortex studied by multi-probe microdialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300114

Mechanisms of action of atypical antipsychotic drugs: a critical analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300114

Double activity imaging reveals distinct cellular targets of haloperidol, clozapine and dopamine D(3) receptor selective RGH-1756.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300114

Dopamine D3 receptor mRNA and binding sites in human brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300114

Role of the dopamine D3 receptor in reactivity to cocaine-associated cues in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300114

Olanzapine increases in vivo dopamine and norepinephrine release in rat prefrontal cortex, nucleus accumbens and striatum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300114

The dopamine hypothesis of schizophrenia: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300114

Involvement of the septohippocampal cholinergic system in representational memory.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300114

Induction of c-fos mRNA Expression in Rat Striatum by Neuroleptic Drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300114

Acute effects of typical and atypical antipsychotic drugs on the release of dopamine from prefrontal cortex, nucleus accumbens, and striatum of the rat: an in vivo microdialysis study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300114

Induction of cortical cholinergic hypofunction and memory retention deficits through intracortical AF64A infusions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300114

Localization of dopamine D3 receptors to mesolimbic and D2 receptors to mesostriatal regions of human forebrain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300114

Differential expression of c-fos and zif268 in rat striatum after haloperidol, clozapine, and amphetamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300114

Systemic administration of amperozide, a new atypical antipsychotic drug, preferentially increases dopamine release in the rat medial prefrontal cortex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300114

Selective inhibition of cocaine-seeking behaviour by a partial dopamine D3 receptor agonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300114

Neuroleptics increase c-fos expression in the forebrain: contrasting effects of haloperidol and clozapine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300114

Nerve growth factor increases extracellular acetylcholine levels in the parietal cortex and hippocampus of aged rats and restores object recognition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300114

Antipsychotic drug doses and neuroleptic/dopamine receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300114

Opposite effects of dopamine D2 and D3 receptors on learning and memory in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300114

Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300114

Novel dopamine receptors half a decade later

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300114

D3 dopamine receptor mRNA is widely expressed in the human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300114

Contribution of blockade of the noradrenaline carrier to the increase of extracellular dopamine in the rat prefrontal cortex by amphetamine and cocaine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300114

Effects of the dopamine D3 receptor agonist, R(+)-7-hydroxy-N,N-di-n-propyl-2-aminotetralin, on memory processes in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300114

Cortical maldevelopment, anti-psychotic drugs, and schizophrenia: a search for common ground

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300114

Antipsychotic drugs classified by their effects on the release of dopamine and noradrenaline in the prefrontal cortex and striatum

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300114

Possible involvement of central cholinergic system in ameliorating effects of indeloxazine, a cerebral activator, on disturbance of learning behavior in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300114

Local application of SCH 39166 reversibly and dose-dependently decreases acetylcholine release in the rat striatum

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300114

7 January 2021

Dopaminergic regulation of striatal acetylcholine release: the critical role of acetylcholinesterase inhibition.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300114

7 January 2021

Noradrenergic modulation of midbrain dopamine cell firing elicited by stimulation of the locus coeruleus in the rat

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300114

7 January 2021

Local influence of endogenous norepinephrine on extracellular dopamine in rat medial prefrontal cortex

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300114

7 January 2021

Receptor mechanisms mediating clozapine-induced c-fos expression in the forebrain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300114

7 January 2021

Neostigmine influences the L-dopa-induced extracellular dopamine levels in the striatum

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300114

7 January 2021

Effects of D3-preferring agonists 7-OH-PIPAT and PD-128,907 on motor behaviors and place conditioning.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300114

7 January 2021

Overcoming the neuroleptic-induced deficit syndrome: clinical observations with remoxipride

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300114

7 January 2021

Effects of clozapine on psychiatric symptoms, cognition, and functional outcome in schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300114

7 January 2021

Molecular Biology of Dopamine Receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300114

7 January 2021

Differential effects of locally administered clozapine and haloperidol on dopamine efflux in the rat prefrontal cortex and caudate-putamen

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300114

7 January 2021

Amisulpride vs. risperidone in the treatment of acute exacerbations of schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300114

7 January 2021

In vivo olanzapine occupancy of muscarinic acetylcholine receptors in patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300114

7 January 2021

Comparative dopaminergic and muscarinic antagonist activity of clozapine and haloperidol

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300114

7 January 2021

Adaptive increase in D3 dopamine receptors in the brain reward circuits of human cocaine fatalities

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300114

7 January 2021

BIMG 80, a novel potential antipsychotic drug: evidence for multireceptor actions and preferential release of dopamine in prefrontal cortex.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300114

7 January 2021

Dopamine D3 receptor antagonism inhibits cocaine-seeking and cocaine-enhanced brain reward in rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300114

7 January 2021

Regulation of extracellular dopamine by the norepinephrine transporter.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300114

7 January 2021

Identifiers

DOI

10.1038/SJ.NPP.1300114

0 references

1 reference